name:-0.044693946838379
name:-0.038946866989136
name:-0.010254144668579
Palatin Technologies, Inc. Patent Filings

Palatin Technologies, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Palatin Technologies, Inc..The latest application filed is for "orally active melanocortin receptor-4 compounds".

Company Profile
19.79.78
  • Palatin Technologies, Inc. - Cranbury NJ
  • Palatin Technologies, Inc - Cranbury NJ
  • Palatin Technologies Incorporated - Cranbury NJ
  • PALATIN TECHNOLOGIES, INC. - 4-C Cedar Brook Drive Cranbury NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Orally Active Melanocortin Receptor-4 Compounds
App 20220204450 - Bullington; James ;   et al.
2022-06-30
Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy
Grant 11,286,280 - Yang , et al. March 29, 2
2022-03-29
Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery
App 20220088146 - Dodd; John Harold ;   et al.
2022-03-24
Use Of Bremelanotide In Patients With Controlled Hypertension
App 20210220444 - Krop; Julie ;   et al.
2021-07-22
Orally Active Melanocortin Receptor-4 Compounds
App 20210198201 - Bullington; James ;   et al.
2021-07-01
Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction
App 20210060120 - Spana; Carl ;   et al.
2021-03-04
Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy
App 20200339631 - Yang; Wei ;   et al.
2020-10-29
Therapies for Obesity, Diabetes and Related Indications
App 20200276275 - Spana; Carl ;   et al.
2020-09-03
Melanocortin receptor-specific peptide with C-terminal naphthylalanine
Grant 10,711,039 - Yang , et al.
2020-07-14
Therapies for obesity, diabetes and related indications
Grant 10,660,939 - Spana , et al.
2020-05-26
Melanocortin receptor-specific peptides
Grant 10,632,171 - Shi , et al.
2020-04-28
Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction
App 20190216888 - Spana; Carl ;   et al.
2019-07-18
Melanocortin Receptor-Specific Peptides
App 20190216887 - Shi; Yi-qun ;   et al.
2019-07-18
Uses of bremelanotide in therapy for female sexual dysfunction
Grant 10,286,034 - Spana , et al.
2019-05-14
Melanocortin receptor-specific peptides
Grant 10,179,804 - Shi , et al. Ja
2019-01-15
Melanocortin-1 receptor-specific linear peptides
Grant 10,106,578 - Yang , et al. October 23, 2
2018-10-23
Melanocortin-1 receptor-specific cyclic hexapeptides
Grant 10,017,539 - Yang , et al. July 10, 2
2018-07-10
Therapies for Obesity, Diabetes and Related Indications
App 20180153965 - Spana; Carl ;   et al.
2018-06-07
Melanocortin Receptor-Specific Peptide with C-Terminal Naphthylalanine
App 20180148478 - Yang; Wei ;   et al.
2018-05-31
Uses of Bremelanotide in Therapy for Female Sexual Dysfunction
App 20180085425 - Spana; Carl ;   et al.
2018-03-29
Uses of bremelanotide in therapy for female sexual dysfunction
Grant 9,700,592 - Spana , et al. July 11, 2
2017-07-11
Melanocortin-1 Receptor-Specific Linear Peptides
App 20170145056 - Yang; Wei ;   et al.
2017-05-25
Replacement Therapy for Natriuretic Peptide Deficiencies
App 20170087205 - Spana; Carl ;   et al.
2017-03-30
Melanocortin-1 receptor-specific linear peptides
Grant 9,580,466 - Yang , et al. February 28, 2
2017-02-28
Melanocortin-1 Receptor-Specific Cyclic Hexapeptides
App 20170008931 - Yang; Wei ;   et al.
2017-01-12
Replacement Therapy for Natriuretic Peptide Deficiencies
App 20160354443 - Spana; Carl ;   et al.
2016-12-08
Melanocortin Receptor-Specific Peptides
App 20160318977 - Shi; Yi-qun ;   et al.
2016-11-03
Melanocortin receptor-specific heptapeptides
Grant 9,458,201 - Shi , et al. October 4, 2
2016-10-04
Melanocortin-1 receptor-specific cyclic peptides
Grant 9,447,148 - Yang , et al. September 20, 2
2016-09-20
Uses of bremelanotide in therapy for female sexual dysfunction
Grant 9,352,013 - Spana , et al. May 31, 2
2016-05-31
Lactam-bridged melanocortin receptor-specific peptides
Grant 9,273,098 - Chen , et al. March 1, 2
2016-03-01
Uses of Bremelanotide in Therapy for Female Sexual Dysfunction
App 20150231196 - Spana; Carl ;   et al.
2015-08-20
Melanocortin-1 Receptor-Specific Linear Peptides
App 20150119341 - Yang; Wei ;   et al.
2015-04-30
Melanocortin-1 Receptor-Specific Cyclic Peptides
App 20150038434 - Yang; Wei ;   et al.
2015-02-05
Melanocortin-1 receptor-specific linear peptides
Grant 8,933,194 - Yang , et al. January 13, 2
2015-01-13
Uses Of Bremelanotide in Therapy for Female Sexual Dysfunction
App 20140378392 - Spana; Carl ;   et al.
2014-12-25
Melanocortin Receptor-Specific Heptapeptides
App 20140357575 - Shi; Yi-qun ;   et al.
2014-12-04
Melanocortin-1 receptor-specific cyclic peptides
Grant 8,877,890 - Yang , et al. November 4, 2
2014-11-04
Melanocortin receptor-specific peptides
Grant 8,846,601 - Shi , et al. September 30, 2
2014-09-30
Uses of natriuretic peptide constructs
Grant 8,828,926 - Bastos , et al. September 9, 2
2014-09-09
Melanocortin receptor-specific peptides for treatment of female sexual dysfunction
Grant 8,729,224 - Shi , et al. May 20, 2
2014-05-20
Cyclic natriuretic peptide constructs
Grant 8,580,747 - Sharma , et al. November 12, 2
2013-11-12
Amide linkage cyclic natriuretic peptide constructs
Grant 8,580,746 - Sharma , et al. November 12, 2
2013-11-12
Melanocortin-1 Receptor-Specific Cyclic Peptides
App 20130296256 - Yang; Wei ;   et al.
2013-11-07
Melanocortin Receptor-Specific Peptides for Treatment of Female Sexual Dysfunction
App 20130288987 - Shi; Yi-Qun ;   et al.
2013-10-31
Uses of Natriuretic Peptide Constructs
App 20130274207 - Bastos; Margarita ;   et al.
2013-10-17
Melanocortin-1 receptor-specific cyclic peptides
Grant 8,492,517 - Yang , et al. July 23, 2
2013-07-23
Melanocortin receptor-specific peptides for treatment of sexual dysfunction
Grant 8,487,073 - Shi , et al. July 16, 2
2013-07-16
Uses of Natriuretic Peptide Constructs
App 20130045928 - Bastos; Margarita ;   et al.
2013-02-21
Melanocortin receptor-specific spiro-piperidine compounds
Grant 8,263,608 - Shi , et al. September 11, 2
2012-09-11
Melanocortin-1 Receptor-Specific Cyclic Peptides
App 20120225828 - Yang; Wei ;   et al.
2012-09-06
Melanocortin-1 Receptor-Specific Linear Peptides
App 20120225831 - Yang; Wei ;   et al.
2012-09-06
N-alkylated cyclic peptide melanocortin agonists
Grant 8,247,530 - Sharma , et al. August 21, 2
2012-08-21
Melanocortin Receptor-Specific Peptides
App 20120178701 - Shi; Yi-qun ;   et al.
2012-07-12
Lactam-Bridged Melanocortin Receptor-Specific Peptides
App 20120077957 - Chen; Xin ;   et al.
2012-03-29
Linear and cyclic melanocortin receptor-specific peptidomimetics
Grant 8,114,844 - Sharma , et al. February 14, 2
2012-02-14
Peptidic Constructs with Amino Acid Surrogates
App 20110263818 - SHARMA; SHUBH D. ;   et al.
2011-10-27
Melanocortin Receptor-Specific Spiro-Piperidine Compounds
App 20110178080 - Shi; Yi-Qun ;   et al.
2011-07-21
Melanocortin receptor-specific piperazine compounds with diamine groups
Grant 7,968,548 - Sharma , et al. June 28, 2
2011-06-28
Melanocortin receptor-specific compounds
Grant 7,964,601 - Sharma , et al. June 21, 2
2011-06-21
Amino acid surrogates for peptidic constructs
Grant 7,964,181 - Sharma , et al. June 21, 2
2011-06-21
Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction
App 20110065652 - Shi; Yi-Qun ;   et al.
2011-03-17
Cyclic peptide compositions for treatment of sexual dysfunction
Grant 7,897,721 - Sharma , et al. March 1, 2
2011-03-01
N-Alkylated Cyclic Peptide Melanocortin Agonists
App 20110009341 - Sharma; Shubh D. ;   et al.
2011-01-13
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
Grant 7,834,017 - Burris , et al. November 16, 2
2010-11-16
Peptidomimetics of biologically active metallopeptides
Grant 7,807,678 - Sharma , et al. October 5, 2
2010-10-05
Linear natriuretic peptide constructs
Grant 7,795,221 - Sharma , et al. September 14, 2
2010-09-14
Peptide compositions for treatment of sexual dysfunction
Grant 7,795,378 - Sharma , et al. September 14, 2
2010-09-14
Linear melanocortin receptor-specific peptides for cachexia
Grant 7,754,691 - Sharma July 13, 2
2010-07-13
Naphthalene-containing melanocortin receptor-specific small molecule
Grant 7,732,451 - Sharma , et al. June 8, 2
2010-06-08
Melanocortin receptor-specific piperazine and keto-piperazine compounds
Grant 7,727,990 - Sharma , et al. June 1, 2
2010-06-01
Substituted melanocortin receptor-specific single acyl piperazine compounds
Grant 7,727,991 - Sharma , et al. June 1, 2
2010-06-01
Substituted melanocortin receptor-specific piperazine compounds
Grant 7,718,802 - Sharma , et al. May 18, 2
2010-05-18
Cyclic Peptide Compositions for Treatment of Sexual Dysfunction
App 20100121027 - Sharma; Shubh D. ;   et al.
2010-05-13
Substituted melanocortin receptor-specific piperazine compounds
Grant 7,709,484 - Sharma , et al. May 4, 2
2010-05-04
Cyclic Natriuretic Peptide Constructs
App 20100075895 - Sharma; Shubh D. ;   et al.
2010-03-25
Amide Linkage Cyclic Natriuretic Peptide Constructs
App 20100035821 - Sharma; Shubh D. ;   et al.
2010-02-11
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
Grant 7,655,658 - Sharma , et al. February 2, 2
2010-02-02
Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
App 20090305960 - Chen; Xin ;   et al.
2009-12-10
Cyclic natriuretic peptide constructs
Grant 7,622,440 - Sharma , et al. November 24, 2
2009-11-24
Pyrrolidine melanocortin-specific compounds
Grant 7,601,753 - Sharma , et al. October 13, 2
2009-10-13
Small Molecule Compositions for Sexual Dysfunction
App 20090253713 - Sharma; Shubh D.
2009-10-08
Small molecule compositions for sexual dysfunction
Grant 7,550,602 - Sharma June 23, 2
2009-06-23
Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity
App 20090081197 - Burris; Kevin D. ;   et al.
2009-03-26
Compounds and Methods for Treating Obesity
App 20090076029 - SHARMA; Shubh D. ;   et al.
2009-03-19
Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics
App 20090069224 - Sharma; Shubh D. ;   et al.
2009-03-12
Cyclic peptide compositions for treatment of sexual dysfunction
Grant 7,473,760 - Sharma , et al. January 6, 2
2009-01-06
Melanocortin receptor-specific compounds
Grant 7,456,184 - Sharma , et al. November 25, 2
2008-11-25
Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds
App 20080255033 - Sharma; Shubh D. ;   et al.
2008-10-16
Melanocortin Receptor-Specific Compounds
App 20080234289 - Sharma; Shubh D. ;   et al.
2008-09-25
Cyclic Peptide Isolation by Spray Drying
App 20080227693 - Choudrie; Rowena Fernandez ;   et al.
2008-09-18
Method of making metallopeptides
Grant 7,425,608 - Sharma , et al. September 16, 2
2008-09-16
Linear and cyclic melanocortin receptor-specific peptides
Grant 7,417,027 - Sharma , et al. August 26, 2
2008-08-26
Metallopeptide compositions for treatment of sexual dysfunction
Grant 7,396,814 - Sharma , et al. July 8, 2
2008-07-08
Metallopeptide compounds
Grant 7,385,025 - Sharma , et al. June 10, 2
2008-06-10
Piperazine melanocortin-specific compounds
Grant 7,354,923 - Sharma , et al. April 8, 2
2008-04-08
Knockout identification of target-specific sites in peptides
Grant 7,351,690 - Sharma , et al. April 1, 2
2008-04-01
Diamine-Containing, Tetra-Substituted Piperazine Compounds Having Identical 1- and 4-Substituents
App 20080070921 - Burris; Kevin ;   et al.
2008-03-20
Cyclic peptides for treatment of cachexia
Grant 7,345,144 - Sharma , et al. March 18, 2
2008-03-18
Cyclic peptides for treatment for cachexia
Grant 7,342,089 - Sharma , et al. March 11, 2
2008-03-11
Bicyclic melanocortin-specific compounds
Grant 7,326,707 - Sharma , et al. February 5, 2
2008-02-05
Melanocortin metallopeptides for treatment of sexual dysfunction
Grant 7,307,063 - Sharma , et al. December 11, 2
2007-12-11
Cyclic Natriuretic Peptide Constructs
App 20070265206 - Sharma; Shubh D. ;   et al.
2007-11-15
Amino Acid Surrogates for Peptidic Constructs
App 20070260040 - Sharma; Shubh D. ;   et al.
2007-11-08
Linear Natriuretic Peptide Constructs
App 20070232546 - Sharma; Shubh D. ;   et al.
2007-10-04
Pyrrolidine Melanocortin-Specific Compounds
App 20070155670 - Sharma; Shubh D. ;   et al.
2007-07-05
Multiple agent therapy for sexual dysfunction
Grant 7,235,625 - Diamond , et al. June 26, 2
2007-06-26
Pyrrolidine melanocortin-specific compounds
Grant 7,189,755 - Sharma , et al. March 13, 2
2007-03-13
Cyclic peptide compositions and methods for treatment of sexual dysfunction
Grant 7,176,279 - Sharma , et al. February 13, 2
2007-02-13
Substituted Melanocortin Receptor-Specific Single Acyl Piperazine Compounds
App 20060287330 - SHARMA; Shubh D. ;   et al.
2006-12-21
Melanocortin Receptor-Specific Piperazine and Keto-Piperazine Compounds
App 20060287332 - SHARMA; Shubh D. ;   et al.
2006-12-21
Melanocortin Receptor-specific Piperazine Compounds With Diamine Groups
App 20060287331 - SHARMA; Shubh D. ;   et al.
2006-12-21
Melanocortin Metallopeptode Combinatorial Libraries and Applications
App 20060240481 - Sharma; Shubh D. ;   et al.
2006-10-26
Tuftsin metallopeptide analogs and uses thereof
Grant 7,097,824 - Sharma August 29, 2
2006-08-29
Cyclic peptide compositions for treatment of sexual dysfunction
App 20060111281 - Sharma; Shubh D. ;   et al.
2006-05-25
Melanocortin metallopeptide constructs, combinatorial libraries and applications
Grant 7,049,398 - Sharma , et al. May 23, 2
2006-05-23
Opioid metallopeptide compositions and methods
App 20060083685 - Sharma; Shubh D. ;   et al.
2006-04-20
Methods for making metallopeptides and metallopeptide libraries
App 20060040324 - Sharma; Shubh D.
2006-02-23
Cyclic peptides for treatment of cachexia
App 20060014676 - Sharma; Shubh D. ;   et al.
2006-01-19
Cyclic peptides for treatment of cachexia
App 20060014194 - Sharma; Shubh D. ;   et al.
2006-01-19
Metallopeptide combinatorial libraries and applications
App 20060003386 - Sharma; Shubh D. ;   et al.
2006-01-05
Opioid metallopeptide compositions and methods
Grant 6,979,436 - Sharma , et al. December 27, 2
2005-12-27
Metallopeptide compounds
App 20050282739 - Sharma, Shubh D. ;   et al.
2005-12-22
Multiple agent therapy for sexual dysfunction
App 20050222014 - Diamond, Lisa E. ;   et al.
2005-10-06
Substituted melanocortin receptor-specific piperazine compounds
App 20050176728 - Sharma, Shubh D. ;   et al.
2005-08-11
Metallopeptide compositions for treatment of sexual dysfunction
App 20050164914 - Sharma, Shubh ;   et al.
2005-07-28
Naphthalene-containing melanocortin receptor-specific small molecule
App 20050130988 - Sharma, Shubh D. ;   et al.
2005-06-16
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
App 20050124636 - Sharma, Shubh D. ;   et al.
2005-06-09
Composition and methods for treatment of sexual dysfunction
App 20050037951 - Blood, Christine H. ;   et al.
2005-02-17
Linear and cyclic melanocortin receptor-specific peptides
App 20050038230 - Sharma, Shubh D. ;   et al.
2005-02-17
Knockout identification of target-specific sites in peptides
App 20040248212 - Sharma, Shubh D. ;   et al.
2004-12-09
Melanocortin receptor-specific compounds
App 20040224957 - Sharma, Shubh D. ;   et al.
2004-11-11
Compositions and methods for treatment of sexual dysfunction
Grant 6,794,489 - Blood , et al. September 21, 2
2004-09-21
Peptidomimetics of biologically active metallopeptides
App 20040171520 - Sharma, Shubh D. ;   et al.
2004-09-02
Pyrrolidine melanocortin-specific compounds
App 20040167201 - Sharma, Shubh D. ;   et al.
2004-08-26
Piperazine melanocortin-specific compounds
App 20040157264 - Sharma, Shubh D. ;   et al.
2004-08-12
Bicyclic melanocortin-specific compounds
App 20040152134 - Sharma, Shubh D. ;   et al.
2004-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed